By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


CytomX Therapeutics, Inc. 

650 Gateway Boulevard
Suite 125
South San Francisco  California  94080-7014  U.S.A.
Phone: 650-515-4987 Fax: 650-351-0353



Company News
Five Prime (FPRX) Adds Former CytomX (CTMX)-Genentech (RHHBY) Immuno-Onco Vet To The Roster 8/18/2017 6:41:09 AM
CytomX (CTMX) Announces Second Quarter 2017 Financial Results and Mid-Year Update Webcast Conference Call 8/8/2017 11:51:14 AM
CytomX (CTMX) To Announce Second Quarter 2017 Financial Results And Provide Mid-Year Update 7/27/2017 10:44:12 AM
CytomX (CTMX) Achieves Development Milestone In Strategic Oncology Collaboration With AbbVie (ABBV) For CD71-Targeting Probody Drug Conjugate 6/29/2017 8:22:34 AM
CytomX (CTMX) Announces Management Team Changes 5/16/2017 12:29:32 PM
CytomX (CTMX) Announces First Quarter 2017 Financial Results 5/5/2017 9:07:01 AM
CytomX (CTMX) To Announce First Quarter 2017 Financial Results 4/28/2017 10:47:02 AM
CytomX (CTMX) Appoints Marion McCourt To Board Of Directors 3/30/2017 8:56:57 AM
CytomX (CTMX) Announces Teleconference And Webcast To Provide Corporate Update 3/20/2017 9:03:26 AM
Bay Area's CytomX (CTMX) Surges as Bristol-Myers Squibb (BMY) Signs Up for 8 More Projects With $200 Million Upfront in Deal Totaling $5 Billion 3/20/2017 5:47:05 AM